The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers

Journal of the Society of Laparoendoscopic Surgeons

Volumn 14, Issue 2, 2010, Pages 155-168

  Nezhat, Farr R ^a   Denoble, Shaghayegh M ^a   Liu, Connie S ^b   Cho, Jennifer E ^a   Brown, Douglas N ^a   Chuang, Linus ^c   Gretz, Herbert ^c   Saharia, Prakash ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytoreduction; Laparoscopy; Ovarian cancer

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; CYSTADENOMA; FEMALE; GYNECOLOGIC SURGERY; HUMAN; LAPAROSCOPY; MALE; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PERITONEUM TUMOR; RETROSPECTIVE STUDY; UTERINE TUBE TUMOR;

ADENOCARCINOMA; AGED; CYSTADENOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 78049513529     PISSN: 10868089     EISSN: 19383797     Source Type: Journal    
DOI: 10.4293/108680810X12785289143990     Document Type: Article

References (34)

1. US National Institutes of Health National Cancer Insti tute. Ovarian Cancer. Available at: http://www.cancer.gov/ cancertopics/types/ovarian Accessed Jan 3, 2010.
2. Bristow RE, Montz FJ, Lagasse LD, et al. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 1999;72:278.
3. Vergote I, van Gorp T, Amant F, Leunen K, Neven P, Ber-teloot P. Timing of debulking surgery in advanced ovarian cancer. Int J Gynecol Cancer. 2008;18 suppl 1:11-19.
4. Nezhat FR, Ezzati M, Chuang L, Shamshirsaz AA, Rahaman J, Gretz H. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol. 2009;200:83.e1-e6.
5. Querleu D, LeBlanc E. Laparoscopic infrarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer. 1994;73:1467-1471.
6. Childers JM, Lang J, Surwit EA, Hatch KD. Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol. 1995;59: 25-33.
7. Leblanc E, Querleu D, Narducci F, Occelli B, Papageorgiou T, Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol. 2004;94: 624-629.
8. Chi DS, Abu-Rustum NR, Sonoda Y, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol. 2005; 192:1614-1619.
9. Tozzi R, Kohler C, Ferrara A, Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol. 2004;93:199-203.
10. Spirtos NM, Eisekop SM, Boike G, Schlaerth JB, Cappellari JO. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol. 2005;193:1645-1649.
11. Leblanc E, Sonoda Y, Narducci F, Ferron G, Querleu D. Laparoscopic staging of early ovarian carcinoma. Curr Opin Obstet Gynecol. 2006;18:407-412.
12. Pomel C, Provencher D, Dauplat J, et al. Laparoscopic staging of early ovarian cancer. Gynecol Oncol. 1995;58:301-306.
13. Ghezzi F, Cromi A, Uccella S, et al. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol. 2007;105:409-413.
14. Leblanc E, Querleu D, Narducci F, et al. Surgical staging of early invasive epithelial ovarian tumors. Semin Surg Oncol. 2000; 19:36-41.
15. Nezhat C, Nezhat F, Nezhat C. Nezhat's Operative Gynecologic Laparoscopy and Hysteroscopy. 3rd ed. New York; Cambridge University Press; 2008.
16. Katz VL, Lentz GM, Lobo RA, Gershenson DM. Comprehensive Gynecology. 5th ed. Philadelphia; Mosby Elsevier; 2007.
17. Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy in ovarian cancer: a paradigm change in the management of ovarian cancer. J Minim Invasive Gynecol. 2009;16:250-262.
18. Krivak TC, Elkas JC, Rose GS, et al. The utility of handassisted laparoscopy in ovarian cancer. Gynecol Oncol. 2005;96: 72-76.
19. Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994;170:974-980.
20. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248-1259.
21. Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol. 1998;71:431-436.
22. Fagotti A, Fanfani F, Ludovisi M, et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol. 2005;96:729-735.
23. Angioli R, Palaia I, Zullo MA, et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol. 2006;100:455-461.
24. Amara DP, Nezhat C, Teng NN, Nezhat F, Rosati M. Operative laparoscopy in the management of ovarian cancer. Surg Laparosc Endosc. 1996;6:38-45.
25. Chi DS, Franklin CC, Levine DA, et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol. 2004;94:650-654.
26. Nezhat CH, Nezhat F, Seidman DS, Nezhat C. Vaginal vault evisceration after total laparoscopic hysterectomy. Obstet Gynecol. 1996 May;87(5 Pt 2):868-870.
27. Nezhat CH, Nezhat F, Nezhat C, Rottenberg H. Laparoscopic repair of a vesicovaginal fistula: a case report. Obstet Gynecol. 1994 May;83(5 Pt 2):899-901.
28. Shakhar G, Ben Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003; 10:972-992.
29. Allendorf JD, Bessler M, Whelan RL. Postoperative immune function varies inversely with the degree of surgical trauma in a murine model. Surg Endosc. 1997;11:427-430.
30. Evans C, Galustian C, Kumar D, Hagger R, Melville DM. Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors. Am J Surg. 2009 Feb;197(2):238-245.
31. Smidt VJ, Singh DM, Hurteau JA, Hurd WW. Effect of carbon dioxide on human ovarian carcinoma cell growth. Am J Obstet Gynecol. 2001;185:1314-1317.
32. Abu-Rustum NR, Sonoda Y, Chi DS, et al. The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer. Gynecol Oncol. 2003;90:431-434.
33. Morice P, Camatte S, Larregain-Fournier D, Thoury A, Duvillard P, Castaigne D. Port-site implantation after laparoscopic treatment of borderline ovarian tumors. Obstet Gynecol. 2004; 104:1167-1170.
34. Nagarsheth NP, Rahaman J, Cohen CJ, Gretz H, Nezhat F. The incidence of port-site metastases in gynecologic cancers. JSLS. 2004;8:133-139.